HCA Healthcare (HCA) FY2020 results: revenue $51.5 billion, up 0.4% on the year
HCA Healthcare, Inc. (HCA) reported revenue of $51.5 billion for fiscal 2020, the year ended 31 December 2020, up 0.4% on the year before. Net income was $3.8 billion, up 7.1%, and diluted earnings per share $10.93. The figures are the company's own, from the 10-K it filed with the SEC on 18 February 2022.
Revenue
$51.5 billion
+0.4% on the year
FY2016FY2020
Operating margin
10.5%
10.2% a year earlier
FY2016FY2020
Net income
$3.8 billion
+7.1% on the year
FY2016FY2020
Diluted EPS
$10.93
+8.5% on the year
FY2016FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
51,533
51,336
46,677
+0.4%
Operating income
5,430
5,244
5,335
+3.5%
Operating margin
10.5%
10.2%
11.4%
Interest expense
1,584
1,824
1,755
-13.2%
Pre-tax income
5,430
5,244
5,335
+3.5%
Income tax
1,043
1,099
946
-5.1%
Effective tax rate
19.2%
21.0%
17.7%
Net income
3,754
3,505
3,787
+7.1%
Net margin
7.3%
6.8%
8.1%
Diluted EPS
$10.93
$10.07
$10.66
+8.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
9,232
7,602
6,761
+21.4%
Capital expenditure
2,835
4,158
3,573
-31.8%
Free cash flow
6,397
3,444
3,188
+85.7%
Free cash flow margin
12.4%
6.7%
6.8%
Cash from investing
-3,393
-5,720
-3,901
Cash from financing
-4,677
-1,771
-3,075
Depreciation and amortisation
2,721
2,596
2,278
+4.8%
Share-based compensation
362
347
268
+4.3%
Buybacks
441
1,031
1,530
-57.2%
Dividends paid
153
550
487
-72.2%
Dividend per share
$0.43
$1.60
$1.40
-73.1%
Diluted shares, weighted
344m
348m
355m
-1.3%
Shares outstanding at period end
339m
338m
343m
+0.3%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
572
-2,808
-4,950
Non-controlling interest
2,320
2,243
2,032
+3.4%
Debt
31,004
33,722
32,821
-8.1%
Operating lease liabilities
1,673
1,499
n/a
+11.6%
Finance lease liabilities
494
470
n/a
+5.1%
Other liabilities
11,427
9,932
9,304
+15.1%
Total liabilities and equity
47,490
45,058
39,207
+5.4%
Fixed assets
23,199
22,715
19,757
+2.1%
Investments
504
462
409
+9.1%
Cash and equivalents
1,793
621
502
+188.7%
Receivables
7,051
7,380
6,789
-4.5%
Inventory
2,025
1,849
1,732
+9.5%
Other assets
12,918
12,031
10,018
+7.4%
Total assets
47,490
45,058
39,207
+5.4%
10-K for the year ended 31 December 2020, filed 18 February 2022: the filing.